Clinical Trials Arena April 12, 2024
The Fujifilm site expansion is set to add 680 jobs to the site and expand Fujifilm’s contract research business and production capacity across North America.
Japanese medtech and imaging giant Fujifilm announced an investment of $1.2bn in its large-scale cell culture as it expands its North Carolina manufacturing facility adding 680 jobs to the site by 2031.
The expansion of Fujifilm’s contract development and manufacturing organisation (CDMO) comes as part of a company-wide drive by Fujifilm Diosynth Biotechnologies to build up its large-scale production capacity across the US and Europe. Part of the funds in this wave of investment will be used to develop a large-scale cell culture facility equipped with eight 20,000l mammalian cell culture bioreactors by 2028.
The...
Today's Sponsors
Today's Sponsor